Functional Mapping of the Nucleoprotein of Ebola Virus

ABSTRACT At 739 amino acids, the nucleoprotein (NP) of Ebola virus is the largest nucleoprotein of the nonsegmented negative-stranded RNA viruses, and like the NPs of other viruses, it plays a central role in virus replication. Huang et al. (Y. Huang, L. Xu, Y. Sun, and G. J. Nabel, Mol. Cell 10:307-316, 2002) previously demonstrated that NP, together with the minor matrix protein VP24 and polymerase cofactor VP35, is necessary and sufficient for the formation of nucleocapsid-like structures that are morphologically indistinguishable from those seen in Ebola virus-infected cells. They further showed that NP is O glycosylated and sialylated and that these modifications are important for interaction between NP and VP35. However, little is known about the structure-function relationship of Ebola virus NP. Here, we examined the glycosylation of Ebola virus NP and further investigated its properties by generating deletion mutants to define the region(s) involved in NP-NP interaction (self-assembly), in the formation of nucleocapsid-like structures, and in the replication of the viral genome. We were unable to identify the types of glycosylation and sialylation, although we did confirm that Ebola virus NP was glycosylated. We also determined that the region from amino acids 1 to 450 is important for NP-NP interaction (self-assembly). We further demonstrated that these amino-terminal 450 residues and the following 150 residues are required for the formation of nucleocapsid-like structures and for viral genome replication. These data advance our understanding of the functional region(s) of Ebola virus NP, which in turn should improve our knowledge of the Ebola virus life cycle and its extreme pathogenicity.

[1]  J. Stephenson,et al.  Measles virus nucleocapsid protein expressed in insect cells assembles into nucleocapsid-like structures. , 1993, The Journal of general virology.

[2]  S. Becker,et al.  Ultrastructural Organization of Recombinant Marburg Virus Nucleoprotein: Comparison with Marburg Virus Inclusions , 2000, Journal of Virology.

[3]  D. Kolakofsky,et al.  Replication of paramyxoviruses. , 1999, Advances in virus research.

[4]  D. Bhella,et al.  Significant differences in nucleocapsid morphology within the Paramyxoviridae. , 2002, The Journal of general virology.

[5]  F. Hanisch,et al.  O-Glycosylation of the Mucin Type , 2001, Biological chemistry.

[6]  D. Bhella,et al.  Investigations into the amino-terminal domain of the respiratory syncytial virus nucleocapsid protein reveal elements important for nucleocapsid formation and interaction with the phosphoprotein. , 2003, Virology.

[7]  M. Tsurudome,et al.  Mapping of domains on the human parainfluenza virus type 2 nucleocapsid protein (NP) required for NP-phosphoprotein or NP-NP interaction. , 1999, The Journal of general virology.

[8]  M. Mavrakis,et al.  Morphology of Marburg virus NP-RNA. , 2002, Virology.

[9]  G. Hart,et al.  O-Glycosylation of Nuclear and Cytosolic Proteins , 2000, The Journal of Biological Chemistry.

[10]  Tokiko Watanabe,et al.  Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics , 2004, Journal of Virology.

[11]  Y. Kawaoka,et al.  Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks , 1997, Journal of virology.

[12]  A. Sanchez,et al.  Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. , 1994, Virology.

[13]  W. G. Kelly,et al.  RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. , 1993, The Journal of biological chemistry.

[14]  J. McCormick,et al.  The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. , 1989, Virology.

[15]  Shinji Watanabe,et al.  Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell Culture , 2002, Journal of Virology.

[16]  R. Tjian,et al.  O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation , 1988, Cell.

[17]  W. Baase,et al.  Characterization of Nucleocapsid Binding by the Measles Virus and Mumps Virus Phosphoproteins , 2004, Journal of Virology.

[18]  B. Tey,et al.  Newcastle disease virus nucleocapsid protein: self-assembly and length-determination domains. , 2003, Journal of General Virology.

[19]  A. Sanchez,et al.  Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses. , 1992, The Journal of general virology.

[20]  M. Billeter,et al.  Domains of the measles virus N protein required for binding to P protein and self-assembly. , 1996, Virology.

[21]  M. Yoneyama,et al.  Control of IRF-3 activation by phosphorylation. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[22]  H. Klenk,et al.  Phosphorylation of VP30 Impairs Ebola Virus Transcription* , 2002, The Journal of Biological Chemistry.

[23]  Ziying Han,et al.  Contribution of Ebola Virus Glycoprotein, Nucleoprotein, and VP24 to Budding of VP40 Virus-Like Particles , 2004, Journal of Virology.

[24]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[25]  R. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. , 2002, Glycobiology.

[26]  J. McCormick,et al.  Descriptive analysis of Ebola virus proteins. , 1985, Virology.

[27]  G. Hart,et al.  Glycosylation of the c-Myc transactivation domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Sonia Sharma,et al.  Convergence of the NF‐κB and Interferon Signaling Pathways in the Regulation of Antiviral Defense and Apoptosis , 2003, Annals of the New York Academy of Sciences.

[29]  M. Yoneyama,et al.  Review: Control of IRF-3 Activation by Phosphorylation , 2002 .

[30]  G. Nabel,et al.  The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. , 2002, Molecular cell.

[31]  Shinji Watanabe,et al.  Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein , 2001, Journal of Virology.

[32]  D. Spehner,et al.  The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly , 1993, Journal of virology.

[33]  Emiko Suzuki,et al.  Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP , 2002, Journal of Virology.

[34]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[35]  G. Hart,et al.  Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. , 2003, Progress in nucleic acid research and molecular biology.

[36]  P. T. Emmerson,et al.  Assembly of recombinant Newcastle disease virus nucleocapsid protein into nucleocapsid-like structures is inhibited by the phosphoprotein. , 1997, The Journal of general virology.

[37]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[38]  Stephan Becker,et al.  Comparison of the Transcription and Replication Strategies of Marburg Virus and Ebola Virus by Using Artificial Replication Systems , 1999, Journal of Virology.

[39]  S. Hazar,et al.  Filoviridae: Marburg and Ebola viruses. , 2000 .

[40]  Ziying Han,et al.  Biochemical and Functional Characterization of the Ebola Virus VP24 Protein: Implications for a Role in Virus Assembly and Budding , 2003, Journal of Virology.